Regeneron Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Regeneron Pharmaceuticals patents 704 in total
| Status | Patent |
|---|---|
Grant | Utility: Antigen-binding proteins that activate the leptin receptor Filling date: 12 Sep 2025 Issue date: 14 Apr 2020 |
Application | Utility: Heavy Chain Constant Regions with Reduced Binding to Fc Gamma Receptors Filling date: 12 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: FIBRILLIN-1 MUTATIONS FOR MODELING NEONATAL PROGEROID SYNDROME WITH CONGENITAL LIPODYSTROPHY Filling date: 12 Sep 2025 Issue date: 9 Apr 2020 |
Application | Utility: FAST PROTEIN SEQUENCING Filling date: 12 Sep 2025 Issue date: 9 Apr 2020 |
Grant | Utility: Production cell line enhancers Filling date: 12 Sep 2025 Issue date: 7 Apr 2020 |
Grant | Utility: Methods and systems for chromatography data analysis Filling date: 12 Sep 2025 Issue date: 7 Apr 2020 |
Application | Utility: METHODS AND COMPOSITIONS FOR TREATING SUBJECTS HAVING RHEUMATOID ARTHRITIS Filling date: 12 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: STERILISATION METHOD Filling date: 12 Sep 2025 Issue date: 2 Apr 2020 |
Application | Utility: HUMANIZED NON-HUMAN ANIMALS WITH RESTRICTED IMMUNOGLOBULIN HEAVY CHAIN LOCI Filling date: 12 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: Genetically Modified Non-Human Animals And Methods Of Use Thereof Filling date: 12 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: NEEDLE SHIELD GRIP DEVICES AND RELATED METHODS Filling date: 12 Sep 2025 Issue date: 26 Mar 2020 |
Application | Utility: METHODS OF MAKING MULTISPECIFIC ANTIGEN-BINDING MOLECULES Filling date: 12 Sep 2025 Issue date: 26 Mar 2020 |
Grant | Utility: Isolating cells expressing secreted proteins Filling date: 12 Sep 2025 Issue date: 24 Mar 2020 |
Application | Utility: AUTO-INJECTOR Filling date: 12 Sep 2025 Issue date: 19 Mar 2020 |
Grant | Utility: Humanized IL-4 and IL-4R.alpha. animals Filling date: 12 Sep 2025 Issue date: 17 Mar 2020 |
Grant | Utility: Use of angiopoietins in promoting blood coagulation and in the treatment of blood coagulation disorders Filling date: 12 Sep 2025 Issue date: 17 Mar 2020 |
Application | Utility: METHODS FOR TREATING OR PREVENTING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF ANGPTL3 Filling date: 12 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: Methods and Systems for Pedigree Enrichment and Family-Based Analyses Within Pedigrees Filling date: 12 Sep 2025 Issue date: 12 Mar 2020 |
Application | Utility: FUCOSYLATION-DEFICIENT CELLS Filling date: 12 Sep 2025 Issue date: 12 Mar 2020 |
Grant | Utility: Nucleic acids encoding high affinity antibodies to human IL-6 receptor Filling date: 12 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Utility: Non-human animals having an engineered ANGPTL8 gene Filling date: 12 Sep 2025 Issue date: 10 Mar 2020 |
Grant | Utility: Mice that produce hybrid antibodies Filling date: 12 Sep 2025 Issue date: 10 Mar 2020 |
Application | Utility: Anti-IL-33 Antibodies and Uses Thereof Filling date: 12 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: Methods for Characterizing Protein Complexes Filling date: 12 Sep 2025 Issue date: 5 Mar 2020 |
Application | Utility: METHODS FOR INHIBITING ATHEROSCLEROSIS BY ADMINISTERING AN INHIBITOR OF PCSK9 Filling date: 12 Sep 2025 Issue date: 5 Mar 2020 |
Grant | Utility: ADAM6 mice Filling date: 12 Sep 2025 Issue date: 3 Mar 2020 |
Application | Utility: Methods for Treating Patients with Familial Hypercholesterolemia Filling date: 12 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: GENETICALLY MODIFIED NON-HUMAN ANIMALS EXPRESSING HUMAN EPO Filling date: 12 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: EFFICIENT SELECTIVITY OF RECOMBINANT PROTEINS Filling date: 12 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: Use of Raman Spectroscopy in Downstream Purification Filling date: 12 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: ANTI-FC EPSILON-R1 ALPHA (FCER1A) ANTIBODIES, BISPECIFIC ANTIGEN-BINDING MOLECULES THAT BIND FCER1A AND CD3, AND USES THEREOF Filling date: 12 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: Therapeutic Protein Selection in Simulated In Vivo Conditions Filling date: 12 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: Anti-Zika Virus Antibodies and Methods of Use Filling date: 12 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: USE OF LC-MS/MS TO QUANTITATE PROTEIN BIOMARKERS Filling date: 12 Sep 2025 Issue date: 27 Feb 2020 |
Application | Utility: LOW AFFINITY FcgR DEFICIENT MICE Filling date: 12 Sep 2025 Issue date: 27 Feb 2020 |
Grant | Utility: Biologically active molecules, conjugates thereof, and therapeutic uses Filling date: 12 Sep 2025 Issue date: 25 Feb 2020 |
Application | Utility: NON-HUMAN ANIMALS HAVING A HUMANIZED PROGRAMMED CELL DEATH 1 GENE Filling date: 12 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: Methods for De Novo Protein Sequencing Filling date: 12 Sep 2025 Issue date: 20 Feb 2020 |
Application | Utility: METHOD AND CHROMATOGRAPHY SYSTEM FOR DETERMINING AMOUNT AND PURITY OF A MULTIMERIC PROTEIN Filling date: 12 Sep 2025 Issue date: 20 Feb 2020 |
Grant | Utility: GPR156 variants and uses thereof Filling date: 12 Sep 2025 Issue date: 18 Feb 2020 |
Grant | Utility: Genetically modified non-human animals and methods of use thereof Filling date: 12 Sep 2025 Issue date: 18 Feb 2020 |
Grant | Utility: Humanized IL-15 animals Filling date: 12 Sep 2025 Issue date: 18 Feb 2020 |
Grant | Utility: Humanized light chain mice Filling date: 12 Sep 2025 Issue date: 18 Feb 2020 |
Application | Utility: ROOM TEMPERATURE STABLE LYOPHILIZED PROTEIN Filling date: 12 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: PHARMACEUTICAL COMPOSITION FOR SAFE AND EFFECTIVE TREATMENT OF KNEE AND/OR HIP PAIN Filling date: 12 Sep 2025 Issue date: 13 Feb 2020 |
Application | Utility: METHODS FOR ASSESSING BINDING AFFINITY OF AN ANTIBODY VARIANT TO THE NEONATAL FC RECEPTOR Filling date: 12 Sep 2025 Issue date: 13 Feb 2020 |
Grant | Utility: Non-human animals having humanized Fc-gamma receptors Filling date: 12 Sep 2025 Issue date: 11 Feb 2020 |
Grant | Utility: Heavy chain constant regions with reduced binding to Fc gamma receptors Filling date: 12 Sep 2025 Issue date: 11 Feb 2020 |
Application | Utility: HUMANIZED C5 ANIMALS Filling date: 12 Sep 2025 Issue date: 6 Feb 2020 |
Application | Utility: HUMAN ANTIBODIES TO GFR ALPHA 3 AND METHODS OF USE THEREOF Filling date: 12 Sep 2025 Issue date: 6 Feb 2020 |
Showing 500 to 550 of 704 patents.